Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Daseke Expects FY23 Adjusted EBITDA Of $185M-$190M, Lower Than Previously Guided Range Of $200M-$210M Owing To Seasonal Softening Of Challenged Rate Environment; Sees FY23 Capital Expenditures Of $155M-$160M From Prior View Of $135M-$145M

Author: Benzinga Newsdesk | November 09, 2023 07:43am

Posted In: DSKE